Market forecasts for 3D bioprinting to 2024
ResearchMoz presents this most up-to-date research on 3D Bioprinting 2014-2024: Applications, Markets and Players.
Drug discovery is a highly expensive process which in most cases will end in failure to gain regulatory clearance (see figure 1). The reason for this high failure rate is related to the lack of sufficiently accurate pre-clinical (prior to human volunteer) testing methodologies which have to date been limited to 2-dimensional human cell assays together with animal testing.
View Full Report at http://www.researchmoz.us/
Visit - http://www.linkedin.com/